CDTX - Cidara Therapeutics GAAP EPS of $0.17 beats by $0.10 revenue of $40.74M beats by $18.06M November, 03 2022 05:51 PM Cidara Therapeutics Inc. Cidara Therapeutics press release ( NASDAQ: CDTX ): Q3 GAAP EPS of $0.17 beats by $0.10 . Revenue of $40.74M (+475.4% Y/Y) beats by $18.06M . For further details see: Cidara Therapeutics GAAP EPS of $0.17 beats by $0.10, revenue of $40.74M beats by $18.06M